Scientific and Medical Findings
- The severe limitations of using total serum bilirubin (BT) alone to guide therapy for diagnosis and treatment of Hyperbilirubinemia are widely recognized
- Scientists and clinicians have found that only unbound bilirubin (Bf) that makes up <1% of BT can enter the brain and cause BIND
- Studies have demonstrated that Bf correlates significantly better with poor neurological outcomes in newborns with Hyperbilirubinemia
- However, there is no automated technology available to clinicians/physicians that can measure both Bf and BT.